[Clinical Edge] What Is Dreampia 0.125% Eye Drop? A Korean Low-Dose Atropine Eye Drop for Myopia Control
Parents often have questions when their child is prescribed a myopia control eye drop:
What is this eye drop? How does it work? Is it safe? Is it available in my country?
Dreampia 0.125% is a prescription eye drop currently used in South Korea for myopia management in children and teenagers.
It is manufactured by Daewoo Pharmaceutical and contains atropine sulfate hydrate 0.125% (1.25 mg/mL).
The goal of this treatment is not to remove existing myopia, but to slow down the progression of myopia over time.
What Is the Active Ingredient in Dreampia 0.125%?
The active ingredient is:
Atropine sulfate hydrate 0.125%
Dreampia 0.125% is provided as a single-use disposable eye drop.
After opening, any remaining solution should be discarded and should not be reused.
Who May Need Dreampia 0.125%?
Low-dose atropine eye drops may be considered for children and teenagers who have a higher risk of progressing myopia.
An ophthalmologist may consider several factors, including:
- Age of the child
- Speed of myopia progression
- Increase in axial length of the eye
- Family history of myopia
- Response to previous myopia control treatments
Not every child with myopia needs atropine eye drops.
The decision to start treatment should be made after a comprehensive eye examination and discussion with an eye care professional.
How Is Dreampia 0.125% Used?
In many cases, low-dose atropine is prescribed as:
One drop once daily, usually before bedtime
However, the exact schedule may vary depending on the child’s condition and the treatment plan.
Always follow the instructions provided by your ophthalmologist.
Can Dreampia Be Used With Orthokeratology (Ortho-K) Lenses?
Yes, in some cases.
Some children use both:
- Orthokeratology (Ortho-K) lenses
- Low-dose atropine eye drops
as part of a combined myopia control strategy.
Because treatment response varies between individuals, regular monitoring is important, including:
- Visual acuity testing
- Refraction measurements
- Axial length measurements
These follow-up examinations help determine whether the treatment is effectively slowing myopia progression.
What Are the Possible Side Effects?
Low-dose atropine is generally well tolerated, but some children may experience:
- Increased sensitivity to light (photophobia)
- Enlarged pupils
- Temporary difficulty focusing on near objects
- Mild stinging after eye drop application
If symptoms are severe or continue for a long time, consult your eye doctor.
Why Are Regular Eye Examinations Important?
Dreampia 0.125% does not cure myopia.
Instead, it is used to slow the rate of myopia progression.
During treatment, regular follow-up is important to monitor:
- Changes in axial length
- Changes in refractive error
- Overall response to treatment
These measurements help doctors decide whether the current management plan should be continued or adjusted.
Availability of Dreampia 0.125%
Dreampia 0.125% is a prescription eye drop used in South Korea.
Availability and prescribing practices for atropine eye drops vary by country. Patients outside Korea should consult their local eye care professional about available myopia control options in their region.
The Bottom Line
Dreampia 0.125% is a Korean prescription low-dose atropine eye drop used for myopia control in children and teenagers.
Key points:
- It slows myopia progression rather than reversing existing myopia
- It is used under ophthalmologist supervision
- Regular monitoring of eye growth and vision is important
- Side effects should be discussed with an eye doctor if they occur
Early and appropriate myopia management can help protect children’s long-term eye health.
댓글
댓글 쓰기